high risk no reward - New Portfolio
Daan Boel
high risk no rewardIndividual Investor
Ranked #47,154 out of 861,174 TipRanks' Investors
Success Rate
53 out of 64
profitable transactions
profitable transactions
Average Return
42.03%
Average return
per transaction
per transaction
Share this portfolio:
Portfolio Gain
1-Month Return▲ 17.40%
6-Month Return▲ 30.69%
12-Month Return▲ 156.51%
YTD Return▲ 22.84%
Total Return▲ 196.81%
Best Trade
Bio
Performance
18.29%0-18.29%
▲ 10.96%
▲ 2.38%
▲ 6.51%
Oct 2025
▼ 3.68%
▲ 0.19%
▲ 3.73%
Nov 2025
▼ 0.10%
▲ 0.08%
▼ 0.08%
Dec 2025
▲ 4.06%
▲ 1.47%
▲ 4.29%
Jan 2026
▼ 1.33%
▼ 0.86%
▲ 2.49%
Feb 2026
▲ 0.52%
▼ 4.94%
▼ 4.68%
Mar 2026
▲ 16.06%
▲ 10.51%
▲ 18.29%
Apr 2026
▲ 2.08%
▼ 0.09%
▲ 1.94%
May 2026
▲ 10.96%▲ 2.38%▲ 6.51%
▼ 3.68%▲ 0.19%▲ 3.73%
▼ 0.10%▲ 0.08%▼ 0.08%
▲ 4.06%▲ 1.47%▲ 4.29%
▼ 1.33%▼ 0.86%▲ 2.49%
▲ 0.52%▼ 4.94%▼ 4.68%
▲ 16.06%▲ 10.51%▲ 18.29%
▲ 2.08%▼ 0.09%▲ 1.94%
Recent Activity
Arlo Technologies
3.76%
▲ 13.81%
4
Sell
May 01, 2026
Vanguard S&P 500 UCITS ETF
5.39%
▲ 5.82%
3
Buy
Apr 14, 2026
iShares $ Treasury Bond 20+ Yr UCITS ETF USD (Accumulating)
―
▼ 0.54%
3
Close
Apr 14, 2026
UnitedHealth
4.5%
▲ 23.69%
2
Buy
Apr 13, 2026
Whitecap Resources
12.72%
▲ 77.33%
6
Buy
Mar 25, 2026
Definium Therapeutics
11.21%
▲ 92.23%
3
Buy
Mar 25, 2026
Qualcomm
2.67%
▲ 5.25%
5
Sell
Mar 25, 2026
SentinelOne
2.55%
▼ 4.72%
3
Sell
Mar 25, 2026
Constellation Software
3.75%
▼ 12.34%
3
Sell
Mar 25, 2026
Nano Nuclear Energy Inc.
2.48%
▼ 28.17%
4
Sell
Mar 25, 2026
Acrivon Therapeutics, Inc.
3.69%
▲ 23.52%
4
Buy
Mar 25, 2026
Crispr Therapeutics AG
5.21%
▲ 13.78%
1
Open
Mar 25, 2026
Avino Silver & Gold
10.72%
▲ 161.88%
6
Buy
Mar 24, 2026
Aya Gold & Silver
8.85%
▲ 56.60%
5
Buy
Mar 24, 2026
Ish.Frf Ndx 100
3.37%
▲ 12.87%
2
Buy
Mar 20, 2026
Vanguard FTSE All-World UCITS ETF
2.1%
▲ 5.48%
2
Buy
Mar 20, 2026
JBS
―
▲ 0.52%
2
Close
Mar 17, 2026
Solaris Energy Infrastructure
5.86%
▲ 235.25%
3
Sell
Mar 16, 2026
Marvell
8.29%
▲ 112.20%
7
Sell
Feb 24, 2026
Adyen
2.89%
▼ 1.41%
1
Open
Feb 18, 2026